Early experience with the agents confirms findings from clinical trials
DeSilva lab pursues mechanisms regulating glutamate in demyelinating diseases
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy